A study of NanoFlu vaccine for prevention of Influenza virus infections.
Phase of Trial: Phase I/II
Latest Information Update: 11 Aug 2017
At a glance
- Drugs NanoFlu vaccine-Novavax (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Therapeutic Use
- 11 Aug 2017 New trial record
- 08 Aug 2017 The company anticipates data from this trial in the fourth quarter of 2017.